Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997-2017.
Niels AdriaenssensRobin BruyndonckxAnn VersportenNiel HensDominique L MonnetGeert MolenberghsHerman GoossensKlaus WeistSamuel Coenennull nullPublished in: The Journal of antimicrobial chemotherapy (2021)
Consumption of MLS did not change significantly over time during 2007-2017, while the proportional consumption of long-acting macrolides increased. Seasonal variation remained high, which suggests that MLS are still prescribed inappropriately in many countries.
Keyphrases